These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3816504)

  • 1. Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
    Rolin O; Bouanchaud DH
    Drugs Exp Clin Res; 1986; 12(11):885-7. PubMed ID: 3816504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminoglycoside resistance of enterobacteria isolated from urinary infections in surgical departments].
    Muntean D; Licker M; Berceanu-Văduva D; Crăciunescu M; Hogea E; Popa M; Adămut M; Rădulescu M; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):99-102. PubMed ID: 19856848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aminoglycoside antibiotics from clinical viewpoint].
    Lüthy R
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):112-25. PubMed ID: 1095500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
    Marsot A; Hraiech S; Cassir N; Daviet F; Parzy G; Blin O; Papazian L; Guilhaumou R
    Int J Antimicrob Agents; 2020 Oct; 56(4):106124. PubMed ID: 32739478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin-resistant Serratia marcescens endophthalmitis.
    Gammon JA; Schwab I; Joseph P
    Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
    Magliulo E; Piantieri G; Cafarelli A; Cruciani M
    Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ; Mandaleris CD; Sande MA
    J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial uptake of habekacin, a novel aminoglycoside antibiotic.
    Matsunaga K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):596-601. PubMed ID: 6376453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.